Mendelsohn Michael

Mendelsohn Michael is listed in filings as Director at Foghorn Therapeutics Inc.. This profile follows SEC Form 4 activity through Jun 17, 2025, including 2 public disclosures. Recent filings connect the profile to Foghorn Therapeutics Inc. (FHTX). The current snapshot covers public activity from Jun 28, 2024 to Jun 17, 2025. Reported amounts are shown as $119.8K to $88.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.